Targeting PI3K/Akt/mTOR Signaling in Cancer

Overview of attention for article published in Frontiers in oncology, April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet
twitter: 6 X users

patent: 1 patent

Citations

dimensions_citation: 1183 Dimensions

Readers on

mendeley: 1191 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 news story.

Multi-Center Study Evidences Greater AE Risks with PK13 Inhibitor use in B-Cell Malignancy-based Clinical Trials Sample

TrialSite News, 11 Dec 2019

A multi-center research team from universities and health systems revealed that treatment with phosphatidylinositol 3-kinase…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.